Ngā hua rapu - Alejandro Villar‐Prados
- E whakaatu ana i te 1 - 6 hua o te 6
-
1
Mechanisms of nuclear content loading to exosomes mā Akira Yokoi, Alejandro Villar‐Prados, Paul A. Oliphint, Jianhua Zhang, Xingzhi Song, Peter De Hoff, Robert Morey, Jinsong Liu, Jason Roszik, Karen Clise-Dwyer, Jared K. Burks, Theresa J. O’Halloran, Louise C. Laurent, Anil K. Sood
I whakaputaina 2019Artigo -
2
Induction of anti-VEGF therapy resistance by upregulated expression of microseminoprotein (MSMP) mā Takashi Mitamura, Sunila Pradeep, Michael H. McGuire, Sherry Y. Wu, Shaolin Ma, Hiroto Hatakeyama, Yasmin A. Lyons, Takeshi Hisamatsu, Kyunghee Noh, Alejandro Villar‐Prados, Xiuhui Chen, Cristina Ivan, Cristian Rodriguez‐Aguayo, Wei Hu, Gabriel López-Berestein, Robert L. Coleman, Anil K. Sood
I whakaputaina 2017Artigo -
3
Macrophage depletion through colony stimulating factor 1 receptor pathway blockade overcomes adaptive resistance to anti-VEGF therapy mā Yasmin A. Lyons, Sunila Pradeep, Sherry Y. Wu, Monika Haemmerle, Jean M. Hansen, Michael J. Wagner, Alejandro Villar‐Prados, Archana S. Nagaraja, Robert Dood, Rebecca A. Previs, Wei Hu, Yang Zhao, Duncan H. Mak, Zhilan Xiao, Brenda Melendez, Gregory Lizée, Imelda Mercado‐Uribe, Keith Baggerly, Patrick Hwu, Jinsong Liu, Willem W. Overwijk, Robert L. Coleman, Anil K. Sood
I whakaputaina 2017Artigo -
4
CD63-mediated cloaking of VEGF in small extracellular vesicles contributes to anti-VEGF therapy resistance mā Shaolin Ma, Lingegowda S. Mangala, Wen Hu, Emine Bayaktar, Akira Yokoi, Wei Hu, Sunila Pradeep, Sanghoon Lee, Paul Piehowski, Alejandro Villar‐Prados, Sherry Y. Wu, Michael H. McGuire, Olivia D. Lara, Cristian Rodriguez‐Aguayo, Christopher J. Lafargue, Nicholas B. Jennings, Karin Rodland, Tao Liu, Vikas Kundra, Prahlad T. Ram, Sundaram Ramakrishnan, Gabriel López-Berestein, Robert L. Coleman, Anil K. Sood
I whakaputaina 2021Artigo -
5
Donor Regulatory T-Cell Therapy to Prevent Graft-Versus-Host Disease mā Everett Meyer, Anna Pavlova, Alejandro Villar‐Prados, Cameron S. Bader, Bryan J. Xie, Lori Muffly, Paul Kim, Katherine C. Sutherland, Sushma Bharadwaj, Saurabh Dahiya, Matthew J. Frank, Sally Arai, Laura Johnston, David B. Miklos, Andrew R. Rezvani, Parveen Shiraz, Surbhi Sidana, Judith A. Shizuru, Wen-Kai Weng, Vaibhav Agrawal, Amy Putnam, Nathaniel B. Fernhoff, John Tamaresis, Ying Lü, Rahul Pawar, James Scott McClellan, Robert Lowsky, Robert S. Negrin
I whakaputaina 2025Artigo -
6
FABP4 as a key determinant of metastatic potential of ovarian cancer mā Kshipra M. Gharpure, Sunila Pradeep, Marta Sans, Rajesha Rupaimoole, Cristina Ivan, Sherry Y. Wu, Emine Bayraktar, Archana S. Nagaraja, Lingegowda S. Mangala, Xinna Zhang, Monika Haemmerle, Wei Hu, Cristian Rodriguez‐Aguayo, Michael H. McGuire, Celia Sze Ling Mak, Xiuhui Chen, Michelle Tran, Alejandro Villar‐Prados, Guillermo N. Armaiz-Peña, Ragini Kondetimmanahalli, Ryan Nini, Pranavi Koppula, Prahlad T. Ram, Jinsong Liu, Gabriel López-Berestein, Keith Baggerly, Lívia S. Eberlin, Anil K. Sood
I whakaputaina 2018Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Biology
Medicine
Cancer
Cancer research
Internal medicine
Angiogenesis
Biochemistry
Chemotherapy
Gene
Immunology
Ovarian cancer
Bevacizumab
Genetics
Microvesicles
Oncology
VEGF receptors
Vascular endothelial growth factor
Vascular endothelial growth factor A
microRNA
Antibody
Cell
Cell biology
Clinical endpoint
Clinical trial
Combination therapy
Computational biology
Computer science
Concomitant
Cumulative incidence
Debulking